Navigation Links
Future Course of New Lethal Avian Flu Outbreak in China Can Be Predicted
Date:4/8/2013

LONDON, April 8, 2013 /PRNewswire/ -- Bioradar UK Ltd. and Replikins Ltd. today announced that when the full H7N9 virus genomic sequences from the first lethal and surviving human cases of the current outbreak of H7N9 are available for analysis, hopefully within a week, their Bioradar Replikins FluForecast® software will be able to determine within 24 hours the likely future course of the outbreak. FluForecast® had previously analyzed the virus genomic sequences in the 2003 SARS coronavirus outbreak and in the 2009 H1N1 influenza virus pandemic (1-4) to successfully predict their respective courses.

Furthermore, BioRadar UK Ltd. and Replikins Ltd. can produce an effective non-biologic synthetic vaccine tailored to the current H7N9 outbreak within seven days as they did with H5N1 (1). This is possible because scientists at Bioradar, UK. Ltd and its affiliate Replikins, Ltd. have discovered a genomic structure, and a technology related to virus rapid replication, infectivity, and lethality named Replikins.

The Replikins genomic technology permits:

1) The prediction of the arrival, geographic location, lethality, and the course of an infection, with an accuracy (p<0.001) recognized by the UN FAO (1)

  • The Replikins genomic software predicted the H1N1 outbreak and pandemic of 2009 by an increase in the genomic Replikin®Count in 2008, one year in advance of the pandemic, as reported by CNN's Dr. Sanjay Gupta (1-3)
  • The increase in genomic Replikins has been counted and seen by
    3D X-ray diffraction in the first real-time tracking of structural genomic changes from pre-pandemic through pandemic clinical states (1).

2) The production of tailored influenza vaccines in 7 days, by solid phase synthesis.

  • Replikins synthetic vaccines, shipped freeze dried, have been shown to be effective against H5N1 and Taura Syndrome viruses (1,2,4).
  • Replikins, Ltd. has developed both a cross-strain ReplikinsTransFlu®Vaccine and a specific H7N9 Replikins vaccine available for further testing.

Contact Samuel Bogoch Email tel 646-320-5910

References:
1.  Nature Precedings.  Bogoch et al, doi:10.1038/npre.2012.6952.1
(see also seven additional  Nature Precedings Publications, Bogoch 2011-2012. http://precedings.nature.com/users/549471c7b195af1864d2f1b1996f60642.
2.  www.replikins.com
3. Dr. Sanjay Gupta of CNN Reports on Replikins (www.replikins.com)
4. Jackwood et al. Avian Diseases 53(4): 613‐617, 2009

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Replikins
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. New 3-D transistors promising future chips, lighter laptops
2. Arteriocyte Takes the Lead in Promoting Building Future Pipeline of Women in STEM Career Fields
3. Discovery of a dark state could mean a brighter future for solar energy
4. Palm Beach Residents to Learn How the Future of Regenerative Medicine Will Combat Aging
5. The future of aerospace takes off in Montreal
6. Quantum dots brighten the future of lighting
7. CAS Names 2012 SciFinder® Future Leaders in Chemistry Program Participants
8. Tom Karagiannis, Ph.D. Awarded Future Fellowship by Australian Research Council (ARC)
9. Future memory
10. Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics: Twease.org
11. Electronics without current: Finnish team to research the future of nanoelectronics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... discussions on a range of subjects including policies, debt and ... Poloz. Speaking at a lecture to the Canadian ... to the country,s inflation target, which is set by both ... "In certain areas there needs to be ... why not sit down and address strategy together?" ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
Breaking Biology News(10 mins):